Nina Tunariu works as a consultant radiologist at The Royal Marsden Hospital in London, UK. Her main interest is in the development of multimodality, whole-body imaging in advanced prostate cancer with a focus on qualifying whole-body MRI with Diffusion Weighted Imaging (DWI) parameters as imaging biomarkers for assessing response in bone metastases.

As the dedicated radiologist for the Drug Development and Prostate Targeted Therapies Group Units at The Royal Marsden Hospital, her daily work includes: leading the units’ imaging meetings and assessing response to therapy; performing research on ultrasound-guided biopsies of soft-tissue disease; and advanced data analysis of the anatomical and functional imaging employed in the Phase 1 to 2 clinical trials within these units.

Dr Tunariu qualified from the University of Medicine Iuliu Hatieganu in Cluj-Napoca, Romania, in 1997. She completed her general medical training at Hammersmith Hospital London, Papworth Hospital Cambridge, UK, and the Royal London Hospital, and her clinical radiology training at Imperial College NHS Trust in London. In October 2008, Dr Tunariu joined The Royal Marsden Hospital and The Institute of Cancer Research to undertake an oncological imaging fellowship; in 2014, she was awarded an MDRes for her thesis entitled Standardisation of Data Analysis Methods for Multiparametric MRI in Phase I Clinical Trials by the University of London.

Her main clinical and research interests concern the integrated application of multimodality functional imaging for tumour response assessment in the context of clinical trials of new anticancer agents. She has a particular interest in evaluation of the role of whole-body multiparametric MRI as a tool for evaluation of therapeutic response to targeted anticancer therapies and of intrapatient tumour heterogeneity.

Nina Tunariu

Royal Marsden Hospital, London

Topic: How Does Next Generation Imaging Guide Treatment Decisions?